Stay updated with breaking news from Asensus Surgical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cantor Fitzgerald reissued their overweight rating on shares of Asensus Surgical (NYSEAMERICAN:ASXC – Free Report) in a report issued on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $1.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and issued a $2.00 price target on shares of Asensus Surgical in a […]
RESEARCH TRIANGLE PARK, N.C., Aug. 23, 2023 -- Asensus Surgical, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of...
Asensus Surgical, Inc. (AMEX:ASXC) Q2 2023 Earnings Call Transcript August 10, 2023 Asensus Surgical, Inc. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.08. Operator: Good afternoon, and welcome to the Asensus Surgical Second Quarter 2023 Business and Financial Update Call. All participants will be in listen-only mode. [Operator Instructions] After today’s […]
The earnings reports continue to roll in for Carolinas-based public companies. Here are the latest reports:
Asensus Surgical announced its second-quarter financial results and shared an update on its Luna surgical robot platform.